Analytical Overview: Bausch Health Companies Inc (BHC)’s Ratios Tell a Financial Story

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Bausch Health Companies Inc’s stock clocked out at $6.19, down -0.64% from its previous closing price of $6.23. In other words, the price has decreased by -$0.64 from its previous closing price. On the day, 0.88 million shares were traded. BHC stock price reached its highest trading level at $6.305 during the session, while it also had its lowest trading level at $6.125.

Ratios:

To gain a deeper understanding of BHC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.49. For the most recent quarter (mrq), Quick Ratio is recorded 0.82 and its Current Ratio is at 1.19.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on August 02, 2024, Downgraded its rating to Underweight and sets its target price to $3 from $9 previously.

On July 10, 2024, Raymond James started tracking the stock assigning a Mkt Perform rating and target price of $8.

Jefferies Upgraded its Hold to Buy on September 20, 2023, whereas the target price for the stock was revised from $9 to $16.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 04 ’24 when Carson Seana sold 6,313 shares for $9.80 per share. The transaction valued at 61,867 led to the insider holds 499,905 shares of the business.

Carson Seana sold 220 shares of BHC for $1,624 on Dec 05 ’23. The EVP, General Counsel now owns 382,925 shares after completing the transaction at $7.38 per share. On Nov 06 ’23, another insider, Carson Seana, who serves as the EVP, General Counsel of the company, sold 43 shares for $7.61 each. As a result, the insider received 327 and left with 384,836 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHC now has a Market Capitalization of 2279350016 and an Enterprise Value of 24285366272. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25. Its current Enterprise Value per Revenue stands at 2.639 whereas that against EBITDA is 8.098.

Stock Price History:

Over the past 52 weeks, BHC has reached a high of $11.46, while it has fallen to a 52-week low of $3.96. The 50-Day Moving Average of the stock is -2.79%, while the 200-Day Moving Average is calculated to be -18.49%.

Shares Statistics:

It appears that BHC traded 3.50M shares on average per day over the past three months and 1995070 shares per day over the past ten days. A total of 365.24M shares are outstanding, with a floating share count of 320.71M. Insiders hold about 12.64% of the company’s shares, while institutions hold 78.16% stake in the company. Shares short for BHC as of 1723680000 were 19978621 with a Short Ratio of 5.70, compared to 1721001600 on 18270547. Therefore, it implies a Short% of Shares Outstanding of 19978621 and a Short% of Float of 5.89.

Dividends & Splits

The stock’s 5-year Average Dividend Yield is 6.52.

Most Popular